This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Mar. 14, 2013

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Please click here to view Eisai's 2012 Oncology Digest. The PDF contains two articles and the final oncology digest.

Please click here to view the webcast on Eisai's 2012 Oncology Digest from the Fall Managed Care Forum.

Register today
Spring Managed Care Forum
May 2-3, 2013
Gaylord Palms
Orlando, Fla.

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts


Announcing the NAMCP Medical Directors Breast Cancer Resource Center. Click here to visit the website.

The FDA has recently approved Skyla, a new hormone-releasing system that is placed in the uterus for the prevention of pregnancy. Click here to view the Press Release in PDF Format!

 




GENOMICS

Racial genes tied to ovarian cancer outcomes
MedPage Today
Disease progression and hazard for recurrence of endometrial cancer were significantly worse in patients with highest degree of African genetic ancestry, researchers reported here. For every 10 percent increase in a patient's African racial genetic admixture, risk of disease progression increased by a hazard ratio of 1.27, according to researchers.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




DNA tool kit goes live online
Nature
The latest shopping website is open for business, offering unusual wares: DNA tools to help biologists to engineer life. The DNA sequences — which allow precise control of gene activity in the bacterium Escherichia coli — are the first output of BIOFAB, which calls itself "the world's first biological design-build facility." Launched in 2009 with a $1.4-million grant from the National Science Foundation, BIOFAB aims to advance synthetic biology by creating standard biological "parts" in the form of DNA sequences that control gene expression.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Discover the Concentra Difference.

Concentra offers medical practice expertise, operational and peer support, and long-term stability to enable your professional and financial success. Our providers work consistent schedules that encourage healthy work-life balance, and experience the satisfaction of working in an environment designed to reduce administrative burden while allowing more time for patient care.
 


Young leukemia patient pinning hopes on gene therapy
The Inquirer
Medical science has been trying for 40 years to harness the immune system to cure cancer, or at least turn it into a docile chronic disease. But after 30 months of testing in more than a dozen adults and children worldwide, excitement over the T cell therapy's unprecedented power continues to build. The treatment, developed at the University of Pennsylvania, has eradicated advanced blood cancers in mere weeks, and is being adapted to attack solid tumors including prostate, pancreatic, ovarian and breast cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Human metabolism map aims to advance personalized medicine
FierceHealthIT
An international team of researchers has created a "Google map" of human metabolism — an important step in understanding the underlying causes of disease. One of its most promising uses will be in helping to develop personalized treatments, the researchers say.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New cell, gene therapies pushing truly personalized medicine closer
Genetic Engineering & Biotechnology News
No aspect of biopharma better epitomizes the goals and promise of delivering personalized medicine to treat and perhaps even cure intractable and disabling diseases than the emerging fields of cell and gene therapy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Research shows promising treatment for diabetic wounds using stem cells
Medical Xpress
Pre-clinical research has generated some very promising findings using adult stem cells for the treatment of diabetic wounds. The work showed that a particular type of stem cell, known as the mesenchymal stem cell, could increase wound healing when applied together with a biomaterial made from collagen.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Breast cancer genetic testing gets covered by healthcare reform (MyHealthNewsDaily)
FDA panel votes to remove long-used osteoporosis drug over cancer risk (The Associated Press via Fox News)
Bendable needles developed to deliver stem cells into brains (Scientific American)
Pricing out prescription genomic medicine (Genetic Engineering & Biotechnology News)
IT changes doctor-patient relationship for better (InformationWeek)

Don't be left behind. Click here to see what else you missed.


Patient's own fat cells may help fight deadly brain cancer
Medical News Today
There is a form of stem cell in the human body that can chase cancer cells. Now a new study from the US suggests brain cancer patients' own fat may provide the best source of these mesenchymal stem cells for delivering treatments directly into the brain after the surgical removal of glioblastoma, the most common and deadliest type of brain tumor.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


EMERGING MEDICAL TECHNOLOGIES


Synthetic speech gets an upgrade
NPR
VideoBriefIf you don't have a voice, who speaks for you? Today there are more than 60 different options for people who need to use synthetic voices to communicate, but for the majority of people who use them, there is a single answer to that question: "Perfect Paul."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Robot combines sensors with adaptive mechanics for smarter stroke rehab
Medgadget
Strokes often cause serious disabilities in those afflicted, and rehab requires stamina from the therapists as well as patients. Relearning the skill of walking means therapists end up resembling soldiers rescuing war wounded, often in pairs holding up a patient and prodding the movement of the legs with various means. This is a hard job that a collaborative effort in Europe hopes to overcome with a new robot that has a bunch of features to improve stroke therapy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MANAGED HEALTHCARE NEWS


Physicians brace for 2 percent sequester pay cut
American Medical News
Physicians caring for Medicare patients said their practices will find keeping up with government mandates and the increasing demand for services more difficult once a 2 percent rate cut hits starting April 1.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Healthcare cuts from vaccinations to research
Kaiser Health News
Sequestration spares Medicaid and almost all of Medicare, but automatic cuts to other federal healthcare programs will make it more difficult for low-income Americans to get maternal and infant care, vaccinate their children and receive treatment for mental illness.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


New heart warning for popular Z-Pak antibiotics
ABC News
VideoBriefAn antibiotic used to treat common infections may carry serious heart risks, according to a new warning from the U.S. Food and Drug Administration. The drug, called azithromycin but sold under the brand names Zithromax and Zmax as Z-Pak capsules, is prescribed for infections of the ears, lungs, sinuses, skin, throat and reproductive organs, according to the FDA. But the antibiotic can interfere with the heart's electrical activity, disturbing its rhythm with potentially fatal consequences.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FAST FACTS
"An estimated more than 22,000 new cases of ovarian cancer will occur in the United States in 2013, according to the National Cancer Institute."


 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Senior Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
March 7, 2013
Feb. 28, 2013
Feb. 21, 2013
Feb. 14, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063